Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramodini B Kale-Pradhan

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Therapeutics and Clinical Risk Management|November 28, 2014
Vulnerable COPD patients with comorbidities: the role of roflumilastMelissa Lipari, Pramodini B Kale-Pradhan
Maturitas|July 6, 2014
Effects of proton pump inhibitors on vitamin B12Sheila M Wilhelm, Pramodini B Kale-Pradhan
Pharmacotherapy|January 27, 2007
Tegaserod for constipation-predominant irritable bowel syndromePramodini B Kale-Pradhan, Sheila M Wilhelm
The Annals of Pharmacotherapy|January 31, 2002
Therapeutic dilemma of fluconazole prophylaxis in intensive careWilliam T Sypula, Pramodini B Kale-Pradhan
Expert Review of Clinical Pharmacology|November 25, 2011
Combination of arginine and omega-3 fatty acids enteral nutrition in critically ill and surgical patients: a meta-analysisSheila M Wilhelm, Pramodini B Kale-Pradhan
Pharmacotherapy|September 20, 2011
Estimating creatinine clearance: a meta-analysisSheila M Wilhelm, Pramodini B Kale-Pradhan
Pharmacotherapy|May 9, 2024
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepixBenjamin A August, Pramodini B Kale-Pradhan
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Daptomycin-associated eosinophilic pneumonia with rechallenge: a case report
Melanie Nickerson, Ashish Bhargava, Pramodini B Kale-Pradhan
The Annals of Pharmacotherapy|December 7, 2024
Ceftobiprole Medocaril: A New Fifth-Generation CephalosporinJustin Zimmerman, Christopher Giuliano, Pramodini B Kale-Pradhan
The Annals of Pharmacotherapy|October 11, 2023
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> InfectionsBenjamin August, Andrew Matlob, Pramodini B Kale-Pradhan
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Therapeutics and Clinical Risk Management|November 28, 2014
Vulnerable COPD patients with comorbidities: the role of roflumilastMelissa Lipari, Pramodini B Kale-Pradhan
Maturitas|July 6, 2014
Effects of proton pump inhibitors on vitamin B12Sheila M Wilhelm, Pramodini B Kale-Pradhan
Pharmacotherapy|January 27, 2007
Tegaserod for constipation-predominant irritable bowel syndromePramodini B Kale-Pradhan, Sheila M Wilhelm
The Annals of Pharmacotherapy|January 31, 2002
Therapeutic dilemma of fluconazole prophylaxis in intensive careWilliam T Sypula, Pramodini B Kale-Pradhan
Expert Review of Clinical Pharmacology|November 25, 2011
Combination of arginine and omega-3 fatty acids enteral nutrition in critically ill and surgical patients: a meta-analysisSheila M Wilhelm, Pramodini B Kale-Pradhan
Pharmacotherapy|September 20, 2011
Estimating creatinine clearance: a meta-analysisSheila M Wilhelm, Pramodini B Kale-Pradhan
Pharmacotherapy|May 9, 2024
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepixBenjamin A August, Pramodini B Kale-Pradhan
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Daptomycin-associated eosinophilic pneumonia with rechallenge: a case report
Melanie Nickerson, Ashish Bhargava, Pramodini B Kale-Pradhan
The Annals of Pharmacotherapy|December 7, 2024
Ceftobiprole Medocaril: A New Fifth-Generation CephalosporinJustin Zimmerman, Christopher Giuliano, Pramodini B Kale-Pradhan
The Annals of Pharmacotherapy|October 11, 2023
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> InfectionsBenjamin August, Andrew Matlob, Pramodini B Kale-Pradhan
Pageof 5